Emma Tinsley
Directeur Général chez Weatherden Ltd.
Profil
Emma Tinsley is currently the Chief Executive Officer at Weatherden Ltd.
since 2020 and an Advisor at Science Creates Ventures LLP since 2020.
Previously, she worked as the Manager-Finance & Operations at International Biotechnology Trust Plc.
She also served as a Principal at SV Health Investors LLP from 2015 to 2018 and at KPMG Audit Plc from 2010 to 2015.
Additionally, she was the Principal at West Kent College from 2009 to 2010.
Ms. Tinsley graduated from the University of Bristol in 2009.
Postes actifs de Emma Tinsley
| Sociétés | Poste | Début |
|---|---|---|
Science Creates Ventures
 Science Creates Ventures Investment ManagersFinance Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom. | Consultant / Advisor | 01/06/2020 |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Directeur Général | 01/06/2020 |
Anciens postes connus de Emma Tinsley
| Sociétés | Poste | Fin |
|---|---|---|
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Corporate Officer/Principal | 01/09/2018 |
KPMG Audit Plc
 KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services KPMG Audit Plc provides accounting services. The company was founded in 1995 and is headquartered in London, GB. | Corporate Officer/Principal | 01/09/2015 |
| West Kent College | Corporate Officer/Principal | 01/09/2010 |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | Directeur Financier/CFO | - |
Formation de Emma Tinsley
| University of Bristol | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
International Biotechnology Trust Plc
 International Biotechnology Trust Plc Investment Trusts/Mutual FundsMiscellaneous International Biotechnology Trust Plc is a closed end investment trust company, which invests in the development staged biotechnology and other life sciences industries. The company was founded on January 1, 1994 and is headquartered in London, the United Kingdom. | Miscellaneous |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
KPMG Audit Plc
KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services KPMG Audit Plc provides accounting services. The company was founded in 1995 and is headquartered in London, GB. | Commercial Services |
Weatherden Ltd.
Weatherden Ltd. BiotechnologyHealth Technology Weatherden Ltd. is a pioneering clinical development consulting group based in London, UK. The British company specializes in scientific strategy, translational medicine, clinical development, diligence preparation, and support for M & A. Weatherden focuses on de-risking programs early and optimizing clinical, regulatory, and commercial pathways to bring life-changing medicines to patients. With over 750 years of combined industry experience, they are dedicated to improving the chances for breakthrough therapies to address unmet clinical needs. The private company, founded by Duncan McHale and Houman Ashrafian, provides trusted advice to biopharma, funds, startups, spin-outs, and nonprofits. Emma Tinsley has been the CEO of the company since 2017. | Health Technology |
Science Creates Ventures
Science Creates Ventures Investment ManagersFinance Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom. | Finance |